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DDT is given credit for having helped 1 bil-
lion people live free from malaria, thus sav-
ing millions of lives. In 1973, after 30 years
of worldwide use of DDT, a World Health
Organization (WHO) report concluded that
the benefits derived from use of this pesti-
cide were far greater than its possible risks
(1). After 25 additional years, the beneﬁts of
DDT can be confirmed, but its stability,
ubiquitous presence, and persistence in the
environment, its accumulation in adipose
tissues, and its estrogenic properties raise
concern about its possible long-term adverse
effects. In addition to a possible carcinogenic
effect, DDT has been reported to affect neu-
robehavioral functions and to be associated
with premature births (2,3). No living
organism may be considered DDT-free.
DDT is stored in all tissues, but the highest
concentration occurs in fat. It has been cal-
culated that it would take between 10 and
20 years for DDT to disappear from an indi-
vidual if exposure would totally cease, but
that DDE would possibly persist throughout
the life span (4). The half-life of plasma
DDE has been estimated to be approxi-
mately 10 years (5).
We give here a brief history of the use
of DDT, examples of its persistence in the
environment, its effects on wildlife, the
results of epidemiologic studies, its estro-
genic effects, and the results of studies that
demonstrate its ability to induce tumors in
laboratory rodents. Our emphasis is on the
possible carcinogenicity of DDT in
humans.
Production and Use
DTT was first synthesized in 1874, but its
insecticidal properties were not discovered
until 1939 (4), and large-scale industrial pro-
duction started in 1943. The low price of
DDT, which fell from $1 U.S. per pound in
1945 to about $0.25 per pound in the
mid-1950s (6), contributed to its worldwide
use. It is of interest that the control of
malaria and typhus during and immediately
after World War II was achieved with rela-
tively small quantities of DDT, while much
more DDT was used after 1945 for the con-
trol of agricultural and forest pests. In the
early 1960s, about 400,000 tons of DDT
were used annually worldwide (70–80% of
which was used for agriculture) (4,7).
All soils have a strong absorptive capacity
for DDT that is related to their organic mat-
ter content. DDT is toxic to freshwater and
marine microorganisms, ﬁshes, amphibians,
and birds. On the basis of ecologic considera-
tions, Sweden was the first country to ban
the use of DDT beginning in January 1970
(8,9). In the former Union of Soviet Socialist
Republics (U.S.S.R.) in 1970, DDT and
DDT-based products were prohibited for use
as pesticides by the U.S.S.R. Ministry of
Health because of their persistence, bioaccu-
mulation, and carcinogenicity (10). In the
U.S.S.R. in 1981, the production and use of
DDT in agriculture were banned (11), but
its use for public health purposes (destruction
of insects such as mosquitoes, malarial plas-
modia, ﬂeas, lice, ticks) was still permitted. In
March 1989, DDT was also banned for
medical-disinfecting purposes. Its use, in lim-
ited volumes, was permitted for medical pur-
poses after epidemiologic alerts and only with
the permission of the state administration for
sanitary matters.
In other countries, most uses of DDT
were banned in 1972 or shortly thereafter
because of its negative impact on wildlife
(12), not because of the evidence for carcino-
genicity in long-term tests in rodents.
Epidemiologic studies that showed no signiﬁ-
cant long-term adverse effects were held to be
more relevant than the experimental evidence
of dose-related induction of liver tumors in
rodents, although studies were carried out on
a limited number of exposed people and had
a relatively short follow-up (7,8,13).
After the prohibition of many of the uses
of DDT as an insecticide in the United States
in 1973, its production and use decreased
rapidly in most industrialized countries. In
1985, however, about 300 tons of DDT were
exported from the United States (8), although
no data are available on current production.
In 1990 DDT was produced by one com-
pany each in Italy, India, and Indonesia with
a total worldwide production estimated at
about 30 million pounds (8,14).
Environmental Pollution
Like most organochlorine insecticides, DDT
is not very acutely toxic, an advantage that
has favored its widespread use. It is slowly
biodegraded, persists for a long time in the
environment, and accumulates in the food
chain and in the tissues of living organisms.
DDT is stored in all tissues, with the highest
accumulation in fat, where repeated expo-
sures, even at low concentrations, result in a
particularly high storage (4). Its widespread,
uncontrolled, intensive use has resulted in
worldwide pollution. DDT residues have
been found in all birds and ﬁshes analyzed,
even in those living in desert areas or in the
depths of the oceans. There was a widespread
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Due to uncontrolled use for several decades, dichlorodiphenyltrichloroethane (DDT), probably
the best known and most useful insecticide in the world, has damaged wildlife and might have
negative effects on human health. This review gives a brief history of the use of DDT in various
countries and presents the results of epidemiologic and experimental studies of carcinogenesis.
Even though its use has been prohibited in most countries for ecologic considerations, mainly
because of its negative impact on wildlife, it is still used in some developing countries for essential
public health purposes, and it is still produced for export in at least three countries. Due to its sta-
bility and its capacity to accumulate in adipose tissue, it is found in human tissues, and there is
now not a single living organism on the planet that does not contain DDT. The possible contri-
bution of DDT to increasing the risks for cancers at various sites and its possible role as an
endocrine disruptor deserve further investigation. Although there is convincing experimental evi-
dence for the carcinogenicity of DDT and of its main metabolites DDE and DDD, epidemiologic
studies have provided contrasting or inconclusive, although prevailingly negative, results. The
presence and persistence of DDT and its metabolites worldwide are still problems of great rele-
vance to public health. Efficient pesticides that do not have the negative properties of DDT,
together with the development of alternative methods to ﬁght malaria, should be sought with the
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Reviewoccurrence of DDT, mainly as its metabolite
DDE, in the eggs of ﬁsh-eating birds, such as
falcons, causing a considerable thinning of
the eggshell. The consequent difficulties in
hatching resulted in a severe population
decline. In parallel, high levels of DDT in
lakes were a cause of reproduction failure in
certain ﬁshes (4,9,12). In spite of banning its
use in many countries, DDT and its metabo-
lites are still found all over the world. 
In the United States, storage of total
DDT in body fat increased from 5 ppm in
1950 to 15.6 ppm in 1956, and decreased
thereafter to 3 ppm in 1980. In Italy the
concentration of DDT in body fat was 4.5
ppm in 1965 and 16.7 ppm in 1970, and
decreased to 8.9 ppm in 1984. In 1984 in
Central America, the total DDT in body fat
was 59.3 ppm (4). Although the concentra-
tions of DDT in humans show a decreasing
trend, those of DDE, which is ingested with
food, in particular fish, remain constant or
are decreasing only slightly. Although it was
reported recently that DDE may be dechlo-
rinated microbially to DDMU [1-chloro-
2,2-bis(4-chlorophenyl)ethane] (15), its
persistence in marine sediments remains a
reason for concern. 
In developing countries there is still a
particularly high exposure to residues of
insecticides, mainly DDT and hexachlorocy-
clohexane, which are present in food. The
current intakes of organochlorine insecti-
cides in developing countries in Asia are up
to 100 times greater than those in more
developed countries, and the estimated
intake of DDT by children is reported to be
100 times greater than the admissible daily
intake (ADI) established by the Food and
Agriculture Organization (FAO)/WHO in
1985 at 0.02 mg/kg (16,17). The body bur-
den of several organochlorine insecticides,
most notably p,p´-DDE [l,l-dichloro-2,2-
bis(p-chlorophenyl)ethylene], is also particu-
larly high among Inuits living in Greenland,
who consume large quantities of fat from sea
mammals (18). In this same population, pre-
natal exposure to DDT and other organochlo-
rine insecticides has been found to affect the
immune status of the children and increase
their susceptibility to infections (19).
In two large cities in the Ukraine, Kiev
and Poltava, 100% of the pregnant women
investigated who had no somatic disease nor
occupational contact with organochlorine
insecticide had DDT and its metabolites in
their blood at concentrations of 0.28–76
µg/L (Kiev: 0.86–76 µg/L; Poltava: 0.28–4.5
µg/L) (20). The high values found in Kiev
may be at least partly attributable to the pres-
ence of a factory producing DDT. Likewise,
100% of women who breast-fed their babies
had organochlorine insecticides in their milk.
The main milk contaminants were DDT and
its metabolites, but hexachlorocyclohexane
was also found, and hexachlorobenzene was
present in 45% of cases. In more than 90%
of cases, the concentration of DDT and its
derivatives was 5.8 µg/L. An important index
of exposure is the content of lipophilic agents
in breast milk fat. DDT was found at 
concentrations of 190–1,400 ng/g of milk
fat, with p,p´-DDE representing 38–95% of
the total content of DDT and its derivatives.
As the daily consumption of breast milk is
about 130 mL/kg of baby weight, the daily
consumption of DDT (and its derivatives)
from exclusive breast-feeding is 0.75–5.6
µg/kg of body weight with a maximum of 52
µg/kg of body weight. These concentrations
greatly exceed the acceptable daily dose
established for the U.S.S.R. (0.0025 µg/kg
of body weight per day), which is still valid
in the Ukraine (21). In another study, sam-
ples of breast milk from 197 women in two
Ukrainian cities (Kiev and Dneprodzerzhinsk)
were analyzed for organochlorine com-
pounds. The median DDE concentration
was 2,500 ng/g of milk fat, which is higher
than that in most, but not all, other reports
from Europe (22).
The levels of DDT in women’s milk have
decreased in most countries around the world
in the last decades, with considerable differ-
ences between rural and urban districts within
the same country. They were between 5,000
and 10,000 µg/kg in milk fat in 1951, and
around 1,000 µg/kg in the late 1990s (23). A
survey carried out in the United States in
1986 showed that all samples of human milk
analyzed contained DDE with levels as high
as 25.4 ppm and median value of 2.4 ppm
(24). In a small proportion of breast-fed
babies in Mexico City, the daily intakes of
DDT still exceeded the level recommended
by the World Health Organization, and the
estimated daily intakes of DDT by infants in
a region of Thailand was up to 20 times
higher than the recommended ADI (25,26). 
Epidemiologic Evidence of
Carcinogenicity
Reports on the long-term adverse effects of
occupational exposure to DDT raised the
suspicion of possible carcinogenic effects in
humans. Many epidemiologic studies were
published up to 1991 in which the authors
reported either positive or negative associa-
tions between exposure to DDT and the
development of tumors in humans.
However, a working group convened by the
International Agency for Research on Cancer
qualified these studies as providing inade-
quate evidence for carcinogenicity in humans
(8). Since then, the results of new epidemio-
logic investigations have become available.
An increased risk for pancreatic cancer after
self-reported exposure to DDT (27,28) and
significant excess incidences of liver cancer
and multiple myeloma were reported after
occupational exposure to DDT (29,30). The
association with an increased risk for pancre-
atic cancer was not confirmed in a subse-
quent study, but the conditions of exposure
were not comparable (31).
Subsequent investigations on the long-
term adverse effects of DDE conﬁrmed the
association between the concentrations of
this metabolite in adipose tissue and an
increased risk for mortality from liver cancer
but did not confirm an increased mortality
rate from cancer of the pancreas or multiple
myeloma (32), nor from non-Hodgkin lym-
phomas (33).
DDT as an Endocrine
Disruptor
A number of reports have indicated that
organochlorine insecticides, including DDT
and its metabolites, may act as endocrine dis-
ruptors (13,34). There is evidence that DDE
is an androgen receptor antagonist, and the
hypothesis has been advanced that DDE may
interact in an additive or multiplicative way
with other endocrine-disruptive environmen-
tal pollutants (35–39). Indirect evidence of
the hormonal activity of DDE comes from
the observed association between levels of
DDE in maternal fat and earlier weaning
(40,41). Because a considerable proportion of
all cancers in women are hormonally medi-
ated, the possibility that xenoestrogenic sub-
stances, such as organochlorine insecticides,
contribute to an increased cancer risk is par-
ticularly alarming (42). Early reports showed
higher concentrations of DDT and DDE in
fat tissue of individuals with mammary can-
cer (43), and an association between DDE
blood levels and mammary cancer was
reported in some epidemiologic studies
(44–46). Subsequent studies provided con-
ﬂicting results, with most of them not con-
firming the association (34,47–59). The
analysis of five large studies carried out in
the United States, which had the limitation
of not considering occupational exposures
nor exposures in utero or during adolescence,
did not provide evidence to support a role of
DDE or polychlorinated biphenyls in
increasing the risk for breast cancer (60).
The hypothesis that minute doses of
organochlorine insecticides act synergistically
to activate human estrogen receptors could
not be confirmed experimentally (39).
However, the available data do not allow
determination of whether the estrogenic
effects of DDT and metabolites are dose
related nor determination of the actual shape
of the dose–response relationship.
A number of experimental studies indicate
that DDT has estrogenic effects in rats: it facil-
itated implantation and maintained pregnancy
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ited the binding in vitro of [3H]-estradiol to
the cytosolic estrogen receptor in utero (63),
and accelerated mammary gland carcinogene-
sis induced by 2-acetylamidophenanthrene
(64). In mice, the uterotropic effect of DDT
increased the weight of the uterus and the
development of pseudoestrus (65). A perma-
nent, functional male-to-female sex reversal
following a single exposure of eggs to o,p´-
DDT was observed in medaka ﬁsh (66).
Experimental Evidence of
Carcinogenicity
The carcinogenicity of DDT and its metabo-
lites has been studied in a number of labora-
tories in animals including nonhuman
primates. Lifetime treatment of mice with
DDT induced liver tumors in a dose-related
manner, and the tumors included overtly
malignant metastasizing hepatoblastomas
(67). The ﬁrst liver tumor in male mice was
seen at 50 weeks after exposure to 250 ppm
of DDT in the diet, and at 65 weeks after
exposure to 50, 10, or 2 ppm. In female mice
the ﬁrst liver tumors were seen at 60 weeks of
age at the dose of 250 ppm of DDT in the
diet, and after 100 weeks of age at the 50-
ppm dose (68).
DDT also induced tumors in mice after
treatment for a limited period of time.
When treatment was continued for 15 or 30
weeks and mice were killed at various inter-
vals, similar proportions of mice bearing
liver tumors were observed 65, 95, and 130
weeks after the beginning of the experiment.
More mice had large liver tumors at 95 and
120 weeks than at 65 weeks. These results
indicate that although no new tumors were
induced after cessation of exposure to DDT,
the persistence of DDT-induced hepatomas
did not depend on the continuous adminis-
tration of DDT because the tumors that
have already appeared continue to grow
(68,69). After treatment of mice with DDT
for six generations at four doses, no increase
in the incidence of liver tumors was observed
from generation to generation, as might have
been expected in the presence of a genotoxic
carcinogen (67).
DDT also increased incidences of lung
tumors and lymphomas in mice, incidences of
liver tumors in rats, and incidences of adrenal
adenomas in hamsters (8). Long-term oral
administration of DDT to nonhuman pri-
mates was reported to result in hepatic toxic-
ity, and a few malignant and benign tumours
at various sites were also found at an inci-
dence that was of borderline statistical signiﬁ-
cance (70). In the absence of tumors in the
controls, the few tumors observed may be
considered to be biologically signiﬁcant, thus
conﬁrming the carcinogenic effect observed
in rodents (71). 
The main metabolites of DDT, p,p´-DDE
and p,p´-DDD [l,l-dichloro-2,2-bis(p,p-
chlorophenylethane], are both carcinogenic.
Exposure to DDE resulted in a high inci-
dence of liver tumors in both male and
female mice (about 100% of treated mice
versus 1% in controls) with the ﬁrst tumors
seen at 50 weeks of age. Exposure to DDD
moderately increased the incidence of liver
tumors in males only, with the ﬁrst tumors
seen at 80 weeks of age, and markedly
increased the incidence of lung tumors in
animals of each sex. The combined exposure
to DDE and DDD resulted in a marked
increase and early appearance of liver tumors
in both sexes with the ﬁrst tumors seen at 70
weeks of age (68,72).
DDT and other organochlorine pesti-
cides are cytochrome P450 inducers, and
reactive products are formed during their
metabolism including free radicals, epoxides,
and acid chloride, which can bind covalently
to cell macromolecules. Tests for genotoxic-
ity gave controversial results. DDT did not
induce DNA damage in bacteria or cultured
rodent and human cells. It induced chromo-
somal aberrations in mouse but not in rat
bone-marrow cells in vivo. DDT, tetra-
chlorodiphenylethane (p,p´-TDE) and p,p´-
DDE inhibited gap-junctional intercellular
communication (4,8). 
By inducing cytochrome P450, DDT
can detoxify some chemical agents and alter
the susceptibility of the organism to their
toxic effects. Thus, DDT prevented the
lethal and adrenolytic effects of 7,12-
dimethylbenz[a]anthracene in rats (73). 
Conclusion
The available epidemiologic and experimen-
tal data indicate that the presence and persis-
tence of DDT and its metabolites worldwide
are still problems of great relevance to public
health. The possible contribution of DDT
and its metabolites to the risks for cancers at
various sites and their possible role as
endocrine disruptors, by themselves and in
combination with other organochlorine
insecticides and xenoestrogenic substances,
deserve further investigation.
It has been recently debated at the
United Nations Environment Program
whether DDT should have been totally
banned together with 11 other persistent
organic pollutants. The total ban of DDT
was sharply criticized; in South Africa, a
temporary total ban on the use of DDT for
indoor spraying resulted in a sudden increase
in malaria (74). Eleven countries in Africa, 7
in Asia, and 5 in Latin America still use
DDT for vector disease control. There is a
general consensus that limited and strictly
controlled use of DDT should be allowed
for public health purposes, in particular
where other effective, safe, and affordable
alternatives are not available, and the bene-
fits are clearly far superior to possible risks
(75). The DDT question has stimulated
heated debates from several scientists, with
emphasis on the tragic consequences that a
total ban of DDT could have in several
developing countries (76). It would be
unjustified to minimize the actual and
potential risks for health and the environ-
ment caused by DDT or to downgrade con-
ﬁrmed evidence of adverse effects in humans
(77), but it is clear that a total ban of DDT
could only be achieved at a cost that poor
countries, which still badly need this insecti-
cide for public health purposes, cannot
afford without substantial and long-term
ﬁnancial help from the richer countries. 
In parallel, efficient pesticides that do
not have the negative properties of DDT
and its metabolites should be sought with
the goal of replacing DDT completely.
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